Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease
- Author
- VENNERI, Annalena1 ; SHANKS, Michael F2 ; STAFF, Roger T3 ; PESTELL, Simon J1 ; FORBES, Katrina E1 ; GEMMELL, Howard G3 ; MURRAY, Alison D4
[1] Cognitive Neuroimaging Research Unit, Department of Psychology, University of Aberdeen, AB24 2UB, United Kingdom
[2] Department of Radiology, University of Aberdeen, AB24 2UB, United Kingdom
[3] Old Age Psychiatry, Royal Cornhill Hospital, Aberdeen, United Kingdom
[4] Department of Bio-Medical Physics and Bio-Engineering, University of Aberdeen and Aberdeen Royal Infirmary, United Kingdom - Source
Neuroreport (Oxford). 2002, Vol 13, Num 1, pp 83-87 ; ref : 28 ref
- ISSN
- 0959-4965
- Scientific domain
- Neurology; Physiology, morphology
- Publisher
- Lippincott Williams and Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antialzheimer Cholinesterase Cognition Débit sanguin régional Démence Alzheimer Encéphale Homme Inhibiteur enzyme Rivastigmine Traitement Carboxylic ester hydrolases Encéphale pathologie Enzyme Esterases Hydrolases Hémodynamique Maladie dégénérative Système nerveux central pathologie Système nerveux pathologie
- Keyword (en)
- Antialzheimer agent Cholinesterase Cognition Regional blood flow Alzheimer disease Brain (vertebrata) Human Enzyme inhibitor Rivastigmine Treatment Carboxylic ester hydrolases Cerebral disorder Enzyme Esterases Hydrolases Hemodynamics Degenerative disease Central nervous system disease Nervous system diseases
- Keyword (es)
- Antialzheimer Cholinesterase Cognición Flujo sanguíneo regional Demencia Alzheimer Encéfalo Hombre Inhibidor enzima Rivastigmina Tratamiento Carboxylic ester hydrolases Encéfalo patología Enzima Esterases Hydrolases Hemodinámica Enfermedad degenerativa Sistema nervosio central patología Sistema nervioso patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 13443075
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/00001756-200201210-00020 
https://dx.doi.org/10.1097/00001756-200201210-00020
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00001756-200201210-00020\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Neuroreport (Oxford)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Neuroreport (Oxf.)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"13\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"83\";s:8:\"\u0000*\u0000epage\";s:2:\"87\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-4965\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VENNERI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Annalena\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"SHANKS, Michael F\";i:1;s:14:\"STAFF, Roger T\";i:2;s:16:\"PESTELL, Simon J\";i:3;s:17:\"FORBES, Katrina E\";i:4;s:17:\"GEMMELL, Howard G\";i:5;s:16:\"MURRAY, Alison D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:31:\"Lippincott Williams and Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00001756-200201210-00020\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Neuroreport (Oxford)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Neuroreport (Oxf.)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"13\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"83\";s:8:\"\u0000*\u0000epage\";s:2:\"87\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-4965\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VENNERI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Annalena\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"SHANKS, Michael F\";i:1;s:14:\"STAFF, Roger T\";i:2;s:16:\"PESTELL, Simon J\";i:3;s:17:\"FORBES, Katrina E\";i:4;s:17:\"GEMMELL, Howard G\";i:5;s:16:\"MURRAY, Alison D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:31:\"Lippincott Williams and Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00001756-200201210-00020\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00001756-200201210-00020\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Neuroreport (Oxford)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Neuroreport (Oxf.)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"13\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"83\";s:8:\"\u0000*\u0000epage\";s:2:\"87\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-4965\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VENNERI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Annalena\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"SHANKS, Michael F\";i:1;s:14:\"STAFF, Roger T\";i:2;s:16:\"PESTELL, Simon J\";i:3;s:17:\"FORBES, Katrina E\";i:4;s:17:\"GEMMELL, Howard G\";i:5;s:16:\"MURRAY, Alison D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:31:\"Lippincott Williams and Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00001756-200201210-00020\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Neuroreport (Oxford)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Neuroreport (Oxf.)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"13\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"83\";s:8:\"\u0000*\u0000epage\";s:2:\"87\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-4965\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VENNERI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Annalena\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"SHANKS, Michael F\";i:1;s:14:\"STAFF, Roger T\";i:2;s:16:\"PESTELL, Simon J\";i:3;s:17:\"FORBES, Katrina E\";i:4;s:17:\"GEMMELL, Howard G\";i:5;s:16:\"MURRAY, Alison D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:31:\"Lippincott Williams and Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1097\/00001756-200201210-00020\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Neuroreport (Oxford)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Neuroreport (Oxf.)\";s:7:\"\u0000*\u0000date\";s:4:\"2002\";s:9:\"\u0000*\u0000volume\";s:2:\"13\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"83\";s:8:\"\u0000*\u0000epage\";s:2:\"87\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0959-4965\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"VENNERI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Annalena\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:6:{i:0;s:17:\"SHANKS, Michael F\";i:1;s:14:\"STAFF, Roger T\";i:2;s:16:\"PESTELL, Simon J\";i:3;s:17:\"FORBES, Katrina E\";i:4;s:17:\"GEMMELL, Howard G\";i:5;s:16:\"MURRAY, Alison D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:31:\"Lippincott Williams and Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
